Increases in fluoroquinolone-resistant neisseria gonorrhoeae - Hawaii and California, 2001

Morbidity and Mortality Weekly Report

Volumn 51, Issue 46, 2002, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038842594     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
2. CDC. Sexually transmitted disease surveillance 2001. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 2002.
3. CDC. Sexually transmitted disease surveillance 2001 supplement: Gonococcal Isolate Surveillance Project (GISP) Annual Report - 2001. Atlanta, Georgia: U.S. Department of Health and Human Services, 2002.
4. Iverson CJ, Wang S, Ohye R, et al. Emergence of a possible endemic focus of ciprofloxacin-resistant Neisseria gonorrhoeae in Hawaii [Abstract]. In: Program and abstracts of the International Conference on Emerging Infectious Diseases. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, July 16-19, 2000.
5. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun Dis Intell 2001;25:274-7.
6. CDC. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;51(No. RR-6).
7. CDC. Discontinuation of cefixime tablets - United States. MMWR 2002;51:1052
8. CDC. Fluoroquinolone-resistance in Neisseria gonorrhoeae in Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR 2000;49:833-6.
9. CDC. Antibiotic-resistant strains of Neisseria gonorrhoeae: policy guidelines for detection, management, and control. MMWR 1987;36 (No. S-5).
10. Roy K, Wang S, Meltzer M. Identifying the optimal diagnostic and treatment strategy for gonorrhea in a time of increasing ciprofloxacin-resistance [Abstract]. In: Program and abstracts of the 2002 Conference on Antimicrobial Resistance. Bethesda, Maryland: National Foundation for Infectious Diseases, June 27-29, 2002.